Globus Medical, Inc.
GMED Healthcare Medical Devices
Globus Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 16.7% from fiscal 2024. In the quarter to June 2026, revenue grew 5.94%, EPS fell 25.3% and free cash flow grew 571.3%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for three.
Follow GMED
Globus Medical, Inc. (GMED) P/E ratio
As of 16 October 2026, Globus Medical, Inc. (GMED) trades at a P/E ratio of 19.3×. Over the past ten years it has ranged from 16.9× (November 2016) to 246× (August 2024); the current reading is higher than 6% of that period. That is below the Medical Devices industry median of 23.2× and below the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 21.9× | (80.11%) |
| FY2024 | 110× | 144.79% |
| FY2023 | 45.1× | 16.38% |
| FY2022 | 38.7× | (20.65%) |
| FY2021 | 48.8× | (22.21%) |
| FY2020 | 62.7× | 68.28% |
| FY2019 | 37.3× | 37.77% |
| FY2018 | 27.1× | (29.82%) |
| FY2017 | 38.5× | 67.92% |
| FY2016 | 23.0× | (2.64%) |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 19.9× | 0.48% |
| Mar 2026 | 19.8× | (9.71%) |
| Dec 2025 | 21.9× | 19.51% |
| Sep 2025 | 18.4× | (18.52%) |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BRKR Bruker Corporation compare | n/m |
| GKOS Glaukos Corporation compare | n/m |
| GMED Globus Medical, Inc. | 19.3× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 23.0× |
| PODD Insulet Corporation compare | 26.4× |
| SNN Smith & Nephew SNATS, Inc. compare | 35.4× |
| BIO Bio-Rad Laboratories, Inc. compare | 42.5× |
| BIO.B Bio-Rad Laboratories, Inc. compare | 43.7× |
| PEN Penumbra, Inc. compare | 78.4× |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)